Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Polynovo ( (AU:PNV) ) has provided an update.
PolyNovo Limited has announced the appointment of Mr. Robert Douglas as a new Non-Executive Director, with a resolution for his election to be proposed at the upcoming Annual General Meeting. Mr. Douglas brings extensive experience from his previous role as Global Chief Operating Officer at ResMed, and his expertise is expected to enhance the board’s skillset and governance, benefiting the company and its stakeholders.
The most recent analyst rating on (AU:PNV) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.
More about Polynovo
PolyNovo Limited operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices. The company is known for its advanced wound care solutions and has a market focus on expanding its presence in the global healthcare sector.
Average Trading Volume: 3,470,170
Technical Sentiment Signal: Sell
Current Market Cap: A$949.9M
For detailed information about PNV stock, go to TipRanks’ Stock Analysis page.